Houston Methodist

Houston Methodist's mission is to provide high quality, cost-effective health care that delivers the best value to the people we serve in a spiritual environment of caring in association with internationally recognized teaching and research.

For a full listing of current courses offering CME credit, visit learn.houstonmethodist.org

To access our ...
read more ↘

 

Eosinophilic Esophagitis - Are We Making Progress?

2,607 views
April 12, 2023

Disclaimer: On February 12, 2024 the FDA approved budesonide oral suspension (EOHILIA), a corticosteroid indicated for 12 weeks of treatment in adult and pediatric patients 11 years of age and older with EoE.

Comments 0
Login to view comments. Click here to Login